急性缺血性卒中取栓患者血栓成分与病因的关联
研究对501份取栓血栓行多参数定量组织学分析,并按TOAST分型确定病因。与大动脉粥样硬化血栓相比,心源性血栓红细胞更少而血小板、纤维蛋白、白细胞和胞外DNA更多;隐源性血栓的红细胞和血小板构成与心源性血栓相似。多变量逻辑回归提示仅凭单个血栓成分难以预测卒中病因。
要点
- 心源性血栓较大动脉粥样硬化血栓含更少红细胞、更多血小板、纤维蛋白、白细胞和胞外DNA。
- 隐源性血栓红细胞较少、血小板较多,构成与心源性血栓相似。
- 多变量逻辑回归提示仅凭单个血栓成分难以预测卒中病因。
核心结论
- 心源性血栓比动脉粥样硬化血栓含更少红细胞和更多血小板,隐源性血栓在红细胞和血小板构成上与心源性血栓相似。
研究设计与样本
- 研究纳入来自AZ Groeninge医院(比利时科特赖克)和CHU Lille(法国里尔)接受取栓治疗的缺血性卒中患者血栓501份。
- 卒中病因由治疗卒中的专科医生按TOAST分型系统确定。
- 对血栓关键成分行广泛组织学分析,分析者对卒中病因设盲,成分包括红细胞、血小板、纤维蛋白、血管性血友病因子、白细胞、瓜氨酸化组蛋白H3(作为中性粒细胞胞外诱捕网标志物)和胞外DNA。
- 定量组织学结果与病因进行关联分析。
主要发现
- 与大动脉粥样硬化血栓相比,心源性血栓含显著更少红细胞和显著更多血小板、纤维蛋白、白细胞和胞外DNA。
- 隐源性血栓含相对少量红细胞和大量血小板,与心源性血栓相似。
- 多变量逻辑回归模型提示仅凭单个血栓成分难以预测卒中病因。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In ischemic stroke due to large vessel occlusion, cerebral blood flow is impaired by thromboemboli, which can originate from various sources in the body. A better understanding of thromboembolus composition can improve our understanding of the underlying pathophysiology and potentially guide improvement of prevention strategies. The aim of this study therefore was to perform a large-sample multi-parameter quantitative histological analysis of retrieved thromboemboli from stroke patients. METHODS: Thromboemboli (n=501) were collected from thrombectomy-treated ischemic stroke patients at AZ Groeninge Hospital (Kortrijk, Belgium) and CHU Lille (Lille, France). Stroke etiology was determined by the treating stroke specialist using the TOAST classification system (Trial of ORG 10172 in Acute Stroke Treatment). Extensive histological analysis, blinded to stroke etiology, was performed for key thrombus constituents including red blood cells (RBCs), platelets, fibrin, von Willebrand Factor, leukocytes, citrullinated histone H3 (as a marker for neutrophil extracellular traps), and extracellular (ex)DNA. Quantitative histology results were linked to etiology. RESULTS: Compared with large-artery atherosclerotic thromboemboli, cardioembolic thromboemboli contained significantly fewer RBCs and significantly more platelets, fibrin, leukocytes, and exDNA. Interestingly, cryptogenic thromboemboli contained relatively low amounts of RBCs and high amounts of platelets, similar to cardioembolic thromboemboli. A multivariable logistic regression model indicated that it is difficult to predict stroke etiology based on the individual thrombus composition. CONCLUSIONS: Based on a large sample cohort of stroke thromboemboli, we found that cardiac thromboemboli contained fewer RBCs and more platelets than atherosclerotic thromboemboli and that cryptogenic thromboemboli have a similar composition to cardiac thromboemboli in terms of RBCs and platelets.
引用
- Staessens S, Vandelanotte S, François O, et al. Association Between Thrombus Composition and Etiology in Patients With Acute Ischemic Stroke Treated by Thrombectomy. Stroke. 2025. PMID: 40127147. doi:10.1161/STROKEAHA.124.047092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。